Amphotericin B Lipid Complex in the Management of Invasive Fungal Infections in Immunocompromised Patients

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.31, Iss.11, 2011-11, pp. : 745-758

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amphotericin B lipid complex for the treatment of invasive fungal infections

By Linden Peter K

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. : 2099-2110

Informa Healthcare

Access to resources Recommend Favorite

Pharmacoeconomic Analysis of Amphotericin B Lipid Complex versus Liposomal Amphotericin B in the Treatment of Fungal Infections

By Kuti J.L.

PharmacoEconomics, Vol. 22, Iss. 5, 2004-01 ,pp. : 301-310

Adis International

Access to resources Recommend Favorite

Liposomal Amphotericin B: Therapeutic Use in the Management of Fungal Infections and Visceral Leishmaniasis

By Coukell A.J. Brogden R.N.

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 585-612

Adis International

Access to resources Recommend Favorite

Liposomal Amphotericin B: A Review of its Use as Empirical Therapy in Febrile Neutropenia and in the Treatment of Invasive Fungal Infections

By Moen Marit D. Lyseng-Williamson Katherine A. Scott Lesley J.

Drugs, Vol. 69, Iss. 3, 2009-02 ,pp. : 361-392

Adis International

Access to resources Recommend Favorite

Amphotericin B Lipid Complex: A Viewpoint by Eric Rosenthal

By Rosenthal Eric

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1912-1913

Adis International

Access to resources Recommend Favorite